Landmark trial may spare thousands of breast cancer patients unnecessary surgery
NCT ID NCT04101851
First seen May 15, 2026 · Last updated May 15, 2026
Summary
This study looks at whether women with aggressive breast cancers (triple-negative or HER2-positive) who have a complete response to chemotherapy can safely avoid sentinel lymph node biopsy. The trial enrolls 350 patients across Europe and will track cancer recurrence in the armpit area over time. If successful, it could reduce surgical side effects like arm swelling and pain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Agaplesion Diakonie Klinikum, Frauenklinik
Hamburg, Germany
-
Albertinen Krankenhaus, Gynäkologie
Hamburg, Germany
-
Asklepios Paulinen Klinik, Frauenklinik
Wiesbaden, Germany
-
Augusta-Klinik Brustzentrum
Bochum, Germany
-
Brustzentrum Klinikum Siloah
Hanover, 30459, Germany
-
Brustzentrum Kreisklinik Ebersberg
Ebersberg, Germany
-
Brustzentrum Nordsachsen, Frauenklinik
Borna, Germany
-
Carl-Thiem-Klinikum, Frauenklinik
Cottbus, Germany
-
DRK Kliniken Köpenick, Brustzentrum
Berlin, Germany
-
Diakonissen-Krankenhaus Brustzentrum
Dresden, Germany
-
Diakonissen-Stiftungs-Krankenhaus, Gynäkologie
Speyer, Germany
-
Elisabeth Krankenhaus, Brustzentrum
Kassel, Germany
-
Evang. Waldkrankenhaus Spandau, Brustzentrum
Berlin, Germany
-
Helios HSK, Brustzentrum
Wiesbaden, Germany
-
Helios Klinik, Gynäkologie
Schkeuditz, Germany
-
Helios Kliniken Schwerin, Frauenklinik
Schwerin, Germany
-
Johanniter-Krankenhaus, Frauenklinik
Stendal, Germany
-
Klinikum Esslingen, Frauenklinik
Esslingen am Neckar, Germany
-
Klinikum Hanau GmbH, Frauenklinik
Hanau, Germany
-
Klinikum Mittelbaden Brustzentrum
Baden-Baden, Germany
-
Klinikum Passau, Frauenklinik
Passau, Germany
-
Kreiskliniken Böblingen, Frauenklinik
Böblingen, Germany
-
Ludmillenstift, Brustzentrum
Meppen, Germany
-
Marienhospital, Klinik für Gynäkologie
Bottrop, Germany
-
Med. Universität Graz, Frauenklinik
Graz, Austria
-
Medizinische Hochschule Hannover, Frauenklinik
Hanover, Germany
-
Praxis Dres. Heinrich & Bangerter
Augsburg, Germany
-
Rems-Murr-Klinik, Frauenklinik
Winnenden, Germany
-
San Raffaele Hospital, Breast Unit
Milan, Italy
-
Sana Klinikum Hameln-Pyrmont
Hamelin, Germany
-
Sana Klinikum Lichtenberg
Berlin, Germany
-
St. Josefs-Hospital, Frauenklinik
Wiesbaden, Germany
-
Stadtkrankenhaus Worms gGmbH, Brustzentrum
Worms, Germany
-
Uni-Klinikum Essen, Frauenklinik
Essen, Germany
-
Universidad de Navarra
Madrid, 28027, Spain
-
Universitäts-Frauenklinik am Klinikum Südstadt
Rostock, Germany
-
Universitäts-Klinikum Magdeburg, Frauenklinik
Magdeburg, Germany
-
Universitäts-Klinikum, Frauenklinik
Augsburg, Germany
-
Universitätsklinikum Heidelberg, Frauenklinik
Heidelberg, Germany
-
ViDia Christliche Kliniken, Frauenklinik
Karlsruhe, Germany
Conditions
Explore the condition pages connected to this study.